| Financial Year |
March 31 2023 |
| Monetary Funds |
447,358,593.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
186,470,024.95 |
| Accounts Receivable |
1,095,688,203.41 |
| Advances to Suppliers |
288,396,073.11 |
| Other Receivables |
44,607,849.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
278,123,742.78 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,427,329.78 |
| Other Current Assets |
22,683,890.82 |
| Total Current Assets |
2,375,424,467.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
8,527,788.71 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
770,166,876.84 |
| Under-construction Projects |
523,877,868.05 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
424,946,835.06 |
| R&D expenses |
26,111,529.01 |
| Goodwill |
125,767,611.14 |
| Long-Term Deferred and Prepaid Expenses |
5,810,278.15 |
| Deferred Income Tax Assets |
95,672,108.78 |
| Other Non-Current Assets |
53,045,999.53 |
| Sub-Total of Non-Current Assets |
2,059,169,748.05 |
| Total Assets |
4,434,594,215.71 |
| Short-Term Loans |
793,432,615.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
38,157,933.27 |
| Accounts Payable |
256,918,952.99 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,197,157.25 |
| Taxes Payable |
19,994,096.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
42,733,899.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
37,646,818.04 |
| Other Current Liabilities |
108,364,925.77 |
| Sub-Total of Current Liabilities |
1,340,578,726.29 |
| Long-term Loans |
135,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,740,532.61 |
| Deferred Income Tax Liabilities |
36,723,367.26 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
262,026,839.02 |
| Total Liabilities |
1,602,605,565.31 |
| Paid-In Capital(Or Share Stock) |
618,222,829.00 |
| Capital Surplus |
305,791,707.49 |
| Surplus Reserve |
159,762,522.46 |
| LESS:Treasury Stock |
59,988,484.99 |
| Undistributed Profits |
1,712,636,206.39 |
| Minority Stockholder's Interest |
123,066,552.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,708,922,097.48 |
| Owner's Equity（Stockholder's Equity） |
2,831,988,650.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,434,594,215.71 |
